A convergence Study on Associated Factors on Metabolic Syndrome among Inpatients with Schizophrenia

조현병 입원환자의 대사증후군 관련요인에 대한 융복합연구

  • Received : 2018.08.07
  • Accepted : 2018.10.20
  • Published : 2018.10.28


Purpose: The purpose of the study was to identify the associated factors on the metabolic syndrome among inpatients with schizophrenia. Methods: The participants were 127 inpatients with schizophrenia from G mental hospital in G city. Collected data were analized with SPSS 22.0 using descriptive statistics, ${\chi}^2$-test, t-test and logistic regression. Results: Metabolic syndrome prevalence of the participants was 46.5%. There were statistically significant differences according to physical disease (${\chi}^2=11.51$, p<.001), body mass index (${\chi}^2=13.59$, p<.001), perception of obesity (${\chi}^2=8.38$, p<.001), and taking olanzapine (${\chi}^2=6.31$, p<.05). Conclusion: Based on the study results, the nursing intervention for prevention and management of metabolic syndrome is needed to develop and provide to schizophrenia patients.


  1. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, & Poirier P. (2010). The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis, Journal of the American College of Cardiology, 56(14), 1113-1132.
  2. H. S. Jang. (2012). There lationship between metabolic syndrome,its components, and cancer incidence in Korean, Unpublished doctoral dissertation, University of Ulsan, Ulsan.
  3. J. I. Chang. (2009). Effects of Metabolic Syndrome on Chronic Kidney Disease. Korean Journal of Urology, 50(3), 261-266.
  4. Glassman AH & Bigger JT Jr. (2001). Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry, 158, 1774-82.
  5. National Rehavilitation Center Rehabilitation Institute. (2016). Disability and Health Statistics. Seoul : National Rehavilitation Center.
  6. K. D. Kang, Y. H. Sea & B. H. Yoon. (2012). Prevalence of Metabolic Syndrome in Chronic Schizophrenic Inpatients. Journal of The Korean Society of Biological Therapies in Psychiatry, 18(2), 281-289.
  7. I. S. Yun, H. S. Go & S. Y. Lee. (2011). A Study of Quality of Life and Body Image in Schizophrenia Patients with Metabolic Syndrome. Clinical psychopharmacology and neuroscience, 22, 208-213.
  8. J. K. Park, S. H. Kweon, Y. H. Kim, M. J. Jang & K. G. Oh (2012). Dietary Behaviors Related to Metabolic Syndrome in Korean Adults. Korean J Community Nutr 17(5), 664-675.
  9. J. W. Roh, Y. S. Cho & A. H. Cho. (2011). The Prevalence of Metabolic Syndrome Among Inpatients with Schizophrenia. Korean Journal of Biological Psychiatry, 18(1), 46-54.
  10. W. J. Kim et al. (2011). Body Weight and Metabolic Changes in First-Episode Psychotic Patients with Antipsychotics Use : A Retrospective Study, Journal of the Korean Society of Biological Therapies, 17(2), 229-238.
  11. Galling B, Roldan A, Nielsen RE, Nielsen J, Gerhard T & Carbon M. (2016). Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis. JAMA psychiatry, 73(3), 247-59.
  12. Wildgust H. J. & Beary, M. (2010). Are there modifiable risk factors which will reduce the excess mortality in schizophrenia? J Psychopharmacology, 24, 37-50.
  13. DE Hert M, Correll CU & Bobes J, Cetkovich-Bakmas M, Cohen D & Asai I. (2011). Physical illness in A patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care, World psychiatry, 10, 52-77.
  14. S. M. Lee, I. H. Shim, Y. S. Woo, J. T. Yeon & W. Y. Park. (2014). A Trend of Medication Prescription Pattern for Outpatients with Bipolar Disorder in a University Hospital: Focusing on Atypical Antipsychotics, Clinical psychopharmacology and neuroscience, 25(3), 124-133.
  15. S. H. Lee & S. H. Cho. (2015). Factors Influencing Metabolic Syndrome among Mental Health Facility Patients with Schizophrenia, J Korean Acad Psychiatr Ment Health Nurs, 25(1), 1-10.
  16. S. M. Joo & K. H. Lee. (2012). Effect of smoking on heart rate variability in patients with schizophrenia, Keimyung Journal of Nursing Science, 16(2), 33-41.
  17. M. O. Kim, H. J. Lee, E. J. Park & K. H. Lee. (2010). Nutrient Intake and Risk of Metabolic Syndrome in Male Smokers. Korean Joutnal of Cpmmunity Nutrition, 15(6), 783-795.
  18. Phutane VH, Tek C, Chwastiak L, Ratliff JC, Ozyuksel B & Woods SW. (2011). Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention? Schizophr Res, 127, 257-61.
  19. Saha S, Chant D & McGrath J. (2007). A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Arch Gen Psychiatry, 64, 1123-1131.
  20. M. K. Park et al. (2012). The Association between Smoking and Prolonged QT Intervals in Schizophrenic Patients. Joutnal of the Korean Society of Biological Therapies in Psychiatry, 18(2), 238-245.
  21. K. R. Park & Y. C. Cho. (2016). Prevalence Rates of Risk Factors of Metabolic Syndrome, and Its Related with Obesity Indices Among the Health Checkup Examinees. Journal of the Korea Academia-Industrial cooperation Society, 17(3), 153-162.
  22. U. Y. Jang et al. (2014). Changes of Body Weight and Metabolic Syndrome in Psychiatric Inpatients ,Clinical psychopharmacology and neuroscience, 25(4), 207-216
  23. Y. Y. Nam, C. S. Kim, C. W. Ahn, K. M Park, B. Ryu, C. H. Kim (2006). Clinical Correlates of Metabolic Syndrome in Patients with Chronic Schizophrenia, Clinical psychopharmacology and neuroscience, 17(4), 335-341.
  24. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R & De Hert M.(2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders: a systematic review and meta-analysis, Schizophr Bull, 39(2), 306-18.
  25. S. U. Lee. (2017). Risk factors for relapse and physical illness in patients with first-episode schizophrenia. Unpublished doctoral dissertation, Kyung Hee University, Seoul.
  26. H. S Cha & H. J. Park. (2016). Effects of Auricular Acupressure on Obesity in Women with Abdominal Obesity. Journal of Korean Academy of Nursing, 46(2), 249-259.
  27. S. G. Min. (2015). Modern psychiatry(6th Edition ). Seoul: ilchokak.
  28. J. S. Lee, J. Y. Kim, J. H. Ann & C. Y. Kim. (2005). Diabetic Ketoacidosis in a Schizophrenic Patient Treated with Olanzapine : A Case Report, Journal of the Korean Neuropsychiatric Association, 44(1), 116-119.
  29. Pramyothin P & Khaodhiar L. (2010). Metabolic syndrome with the atypical antipsychotics, Curr Opin Endocrinol Diabetes Obes, 17, 460-466.
  30. S. H. Kim et al. (2010). Effect of Weight Control Program for Psychiatric Inpatient on Atypical Antipsychotics. Journal of Korean Academy of Nursing, 10(1), 286-286.